|
 |
 |
 |
Hematology Current Events | Hematology News
|
|
|
Sort By:
Page Views | Date |
Tulane pioneers novel ovarian cancer treatment
The Tulane University Section of Hematology and Medical Oncology is investigating a novel treatment for ovarian cancer by using intravenous Ontak to deplete harmful cells that inhibit the body's natural immune response to fight cancer. Ovarian cancer is the fifth leading cancer killer of women in the United States. view more (2005-07-18)
OHSU Cancer Institute research discovery opens new window to understanding chronic myeloid leukemia
Oregon Health & Science University Cancer Institute researchers have opened a new window into the roots of chronic myeloid leukemia (CML). view more (2007-12-10)
Study Finds Blood Cells Can Be Reprogrammed to Act as Embryonic Stem Cells
In a recent study, U.S. researchers have reprogrammed cells found in circulating blood into cells that are molecularly and functionally indistinguishable from embryonic stem cells, a revolutionary achievement that provides a readily accessible source of stem cells and an alternative to harvesting embryonic stem cells. view more (2009-04-21)
WA discovery a key to blood cell development
A West Australian research team has made the world-first discovery a 'pied piper' molecule within blood cells, called Liar, that leads other molecules into the nucleus of the cell, and could offer a key in treating prostate, breast and colon cancers as well as leukemia. view more (2009-04-29)
UC to test targeted treatment for prostate cancer
The American Cancer Society estimates one man in six will get prostate cancer during his lifetime, making it the second-leading cause of cancer death in men. With a new partnership with Areva Med, UC researchers will investigate the use of a new drug in stopping the growth of prostate cancer tumors. view more (2010-04-19)
Genetic markers could predict prostate cancer in younger men, study finds
Prostate cancer has become more common in younger men, and it's often more aggressive in these men. A new study from researchers at the University of Michigan Comprehensive Cancer Center has found that a series of genetic mutations could help detect this early onset prostate cancer. view more (2010-06-08)
Promising results from 2 trials highlighting pomalidomide presented at ASH
Celgene International Sarl (Nasdaq: CELG) today announced that its next IMiDs compound, pomalidomide, has shown promising activity with manageable safety and tolerability for the treatment of relapsed/refractory multiple myeloma (MM) and myelofibrosis. view more (2008-12-11)
Analysis shows revlimid plus dexamethasone increases overall survival in multiple myeloma patients
Celgene International Sarl (NASDAQ: CELG) announced that data from a landmark analysis of patients with relapsed/refractory multiple myeloma found that continuous treatment with REVLIMID (lenalidomide) in combination with dexamethasone after achieving best response resulted in significantly longer overall survival and increased time to disease... view more... (2008-12-11)
Cincinnati Children's researchers publish findings on potential target for leukemia treatment
Cincinnati Children's Hospital Medical Center today announced the publication of pioneering research identifying the crucial role and novel mechanism of action of the protein RhoH GTPase in the development and activation of cells critical to the immune system. view more (2006-10-10)
Genetics determine optimal drug dose of common anticoagulant
Genetic testing can be used to help personalize the therapeutic dosage of warfarin, a commonly-used anticoagulant, according to research published in the September 1, 2007, issue of Blood, the journal of the American Society of Hematology. This result represents one of the first applications of using an individual's genetic information to guide... view more... (2007-08-22)
Anemic Patients With MDS Gain Long-Term Benefits From Erythropoietin and Myeloid Growth Factor Hormones
Myelodysplastic syndromes (MDS), a group of blood disorders that can lead to acute myeloid leukemia (AML) in some patients, often cause severe anemia (when the body lacks a sufficient number of functional red blood cells). view more (2009-09-18)
Ireland Cancer Center researchers advance stem cell gene therapy
Ireland Cancer Center of University Hospitals Case Medical Center researchers have recently made great strides in stem cell gene therapy research by transferring a new gene to cancer patients, via their own stem cells, with the ultimate goal of being able to use stronger chemotherapy treatment with less severe side effects. view more (2007-12-13)
Acupuncture may relieve joint pain caused by some breast cancer treatments
A new study, led by researchers at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center, demonstrates that acupuncture may be an effective therapy for joint pain and stiffness in breast cancer patients who are being treated with commonly used hormonal therapies. Results were published... view more... (2010-03-05)
Keeping cancer at bay: Long-term therapy in the fight against multiple myeloma
There is no known cure for multiple myeloma, so its diagnosis means high-dose chemotherapy followed by repeated treatments with each relapse of the cancer - a watch and wait approach. view more (2006-11-06)
New study finds barriers to pain treatment in children with sickle cell disease
A new study by researchers from the Medical College of Wisconsin, in Milwaukee, found a substantial variation in hydroxyurea utilization for pain and other sickle cell disease complications in children. view more (2009-12-07)
50 Years Of Hairy-Cell Leukemia Research To Be Observed
In 1958, Ohio State University cancer researcher Dr. Bertha Bouroncle first identified a deadly disease now known as hairy-cell leukemia, a once fatal disease that can now be effectively treated. view more (2008-12-08)
UNMC researchers help make diagnostic breakthrough with Burkitt lymphoma; study detailed in New England Journal of Medicine
An international research study involving the University of Nebraska Medical Center, the National Cancer Institute and 10 other institutions has successfully identified the gene expression signature for Burkitt lymphoma. view more (2006-06-12)
New approach to sickle-cell disease shows promise in mice
A new genetic approach to treating sickle cell disease is showing promising results in mice, report researchers from Children's Hospital Boston. view more (2009-12-08)
Cancer study finds adolescents don't get same access to latest treatments as younger patients
The overall survival rate from cancer now is lower in older adolescents and young adults with cancer than in younger children, in part because of a lack of access to clinical trials nationally for the older age group. view more (2008-01-16)
Human term placenta a new abundant source of hematopoietic cells
Investigators at Children's Hospital Oakland Research Institute, Oakland, California found a way to obtain large numbers of hematopoietic stem cell from human term placenta. view more (2009-06-25)
|
|
|
|
Sort By:
Page Views | Date |
|
|
Earth Science News
